EX-10.58





 Exhibit 10.58 

ONCTERNAL THERAPEUTICS, INC. 

2015 EQUITY INCENTIVE PLAN 

STOCK OPTION GRANT NOTICE AND 

STOCK OPTION AGREEMENT 

Oncternal Therapeutics, Inc. (the “Company”), pursuant to its 2015 Equity Incentive Plan (the
“Plan”), hereby grants to Participant an Option to purchase the number of shares of the Company’s Common Stock (referred to herein as “Shares”) set forth below. This Option is subject to all of
the terms and conditions as set forth herein and in the Stock Option Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined
herein, the terms defined in the Plan shall have the same defined meanings in this Stock Option Grant Notice (“Grant Notice”) and the Agreement. 
  

			
	Participant:	  	[Insert Participant Name]
		
	Grant Date:	  	[Insert Grant Date]
		
	Vesting Commencement Date:	  	[Insert Vesting Commencement Date]
		
	Exercise Price per Share:	  	$[Insert Exercise Price Per Share]
		
	Total Exercise Price:	  	$[Insert Aggregate Fair Market Value on Grant Date]
		
	Total Number of Shares Subject to Option:	  	[Insert Number of Shares]
		
	Expiration Date:	  	[Insert tenth anniversary of Grant Date]
		
	Type of Option:	  	☐    Incentive Stock
Option                ☐    Non-Qualified Stock Option
		
	Vesting Schedule:	  	[25% of the total number of shares of Stock subject to the Option (rounded down to the next whole number of shares) shall vest one year after the Vesting Commencement Date, and 1/48th of the total number of shares of Stock subject
to the Option (rounded down to the next whole number of shares) shall vest on the last day of each one-month period of Participant’s service as an Employee, Director or Consultant thereafter, so that all
of the shares of Stock subject to the Option shall be vested on the fourth (4th) anniversary of the Vesting Commencement Date.]

 By his or her signature and the Company’s signature below, Participant agrees to be bound by the terms
and conditions of the Plan, the Agreement and this Grant Notice. Participant has reviewed the Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice
and fully understands all provisions of this Grant Notice, the Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator of the Plan upon any questions arising
under the Plan or the Agreement. 
  

									
	ONCTERNAL THERAPEUTICS, INC.	 	        	  	PARTICIPANT
	By:	 	  
	 		  	By:	 	  

	Print Name:	 	  
	 		  	Print Name:	 	  

	Title:	 	  
	 		  	State of	 	
		 		 		  	Residence:	 	  














 EXHIBIT A 

TO STOCK OPTION GRANT NOTICE 

STOCK OPTION AGREEMENT 

Pursuant to the Grant Notice to which this Agreement is attached, the Company has granted to Participant an Option under the Plan to purchase
the number of Shares indicated in the Grant Notice. 
 1.    Grant of Option. In consideration of
Participant’s past and/or continued employment with or service to the Company and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice, the Company irrevocably grants to Participant an Option
to purchase any part or all of an aggregate of the number of Shares set forth in the Grant Notice at the Exercise Price per Share set forth in the Grant Notice, upon the terms and conditions set forth in the Plan and this Agreement. 

2.    Vesting. The Option shall become vested in such amounts and at such times as are set forth in the
vesting schedule in the Grant Notice. The installments provided for in the vesting schedule are cumulative. No portion of the Option which has not become vested at the date Participant incurs a Termination of Service shall thereafter become vested,
except as may be otherwise provided by the Administrator or as set forth in another written agreement between the Company and Participant. 

3.    Exercise. 

(a)    Duration of Exercisability. Any vested portion of the Option may be exercised in whole or in part at any time
prior to the time when the Option or portion thereof becomes unexercisable under Section 4. 
 (b)    Person
Eligible to Exercise. During the lifetime of Participant, only Participant may exercise the Option or any portion thereof. After the death of Participant, any exercisable portion of the Option may, prior to the time when the Option becomes
unexercisable under Section 4, be exercised by Participant’s personal representative or by any person empowered to do so under the deceased Participant’s will or under the then Applicable Laws of descent and distribution. 

(c)    Manner of Exercise. The Option, or any portion thereof, may be exercised solely by delivery to the Secretary
of the Company or the Secretary’s office, or such other place as may be determined by the Administrator, of all of the following prior to the time when the Option or such portion thereof becomes unexercisable under Section 4: 

(i)    A written exercise notice in substantially in the form attached as Exhibit B to the Grant
Notice (or such other form as is prescribed by the Administrator, which may be an electronic form) (the “Exercise Notice”) signed by Participant or any other person then entitled to exercise the Option or portion thereof,
stating that the Option or portion thereof is thereby exercised, such Exercise Notice complying with all applicable rules established by the Administrator; and 

(ii)    Subject to Section 5(f) of the Plan, full payment for the Shares with respect to which the
Option or portion thereof is exercised by: 
 (A)    Cash or check, payable to the order of the Company;
or 

  
 A-1 













 (B)    With the consent of the Administrator,
surrendering shares of Common Stock then issuable upon exercise of the Option valued at their Fair Market Value on the date of exercise; or 

(C)    On and after the date the Company becomes a Publicly Listed Company, through the (A) delivery
by Participant to the Company of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price or (B) delivery by Participant to the Company of a copy of
irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price; or 

(D)    With the consent of the Administrator, any other form of payment permitted under Section 5(f)
of the Plan; or 
 (E)    any combination of the above permitted forms of payment; and 

(iii)    Subject to Section 9(e) of the Plan, full payment for any applicable withholding taxes in
cash or by check or in the form of consideration permitted by the Administrator for the payment of the exercise price pursuant to Section 3(c)(ii) above or pursuant to Section 3(d) below, which, following the date the Company becomes a
Publicly Listed Company shall include the method provided for in Section 3(c)(ii)(C) above; and 

(iv)    In the event the Option or portion thereof shall be exercised pursuant to Section 3.1 by any
person or persons other than Participant, appropriate proof of the right of such person or persons to exercise the Option. 

(d)    Tax Withholding. The Company shall have the authority and the right to deduct or withhold, or require
Participant to remit to the Company, an amount sufficient to satisfy federal, state, local and foreign taxes (including Participant’s employment tax obligation) required by law to be withheld with respect to any taxable event concerning
Participant arising as a result of the Option or otherwise under this Agreement, including, without limitation, the authority to deduct such amounts from other compensation payable to Participant by the Company. 

(e)    Fractional Shares. The Option may only be exercised for whole shares of Common Stock. Any fractional Shares
shall be rounded down to the nearest whole share. 
 4.    Expiration of Option. The Option may not be
exercised to any extent by anyone after the first to occur of the following events: 
 (a)    The Expiration Date set
forth in the Grant Notice; 
 (b)    The expiration of three months following the date of Participant’s Termination
of Service, unless such Termination of Service occurs by reason of Participant’s death or Disability or Participant’s discharge by the Company for Cause; 

(c)    The expiration of one year following the date of Participant’s Termination of Service by reason of
Participant’s death or Disability; 
 (d)    The date of Participant’s Termination of Service as a result of
Participant’s discharge by the Company for Cause; or 

  
 A-2 













 (e)    With respect to any unvested portion of the Option, the date that
is thirty days following Participant’s Termination of Service for any reason other than as a result of Participant’s discharge by the Company for Cause, or such shorter period as may be determined by the Administrator. 

Participant acknowledges that an Incentive Stock Option exercised more than three months after Participant’s termination of status as an
Employee, other than by reason of death or Disability, will be taxed as a Non-Qualified Stock Option. 

5.    Transferability. The Option shall not be sold, assigned, transferred, pledged or otherwise encumbered
by Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the life of the Participant, the Option shall be exercisable only by the Participant. 

6.    Restrictive Legends and Stop-Transfer Orders.

 (a)    Legends. Participant understands and agrees that the Company shall cause any certificates issued
evidencing the Shares to have the legends set forth below or legends substantially equivalent thereto, together with any other legends that may be required by Applicable Laws: 

THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“ACT”), NOR HAVE THEY BEEN
REGISTERED OR QUALIFIED UNDER THE SECURITIES LAWS OF ANY STATE. NO TRANSFER OF SUCH SECURITIES WILL BE PERMITTED UNLESS A REGISTRATION STATEMENT UNDER THE ACT IS IN EFFECT AS TO SUCH TRANSFER, THE TRANSFER IS MADE IN ACCORDANCE WITH RULE 144 UNDER
THE ACT, OR IN THE OPINION OF COUNSEL (WHICH MAY BE COUNSEL FOR THE COMPANY) REGISTRATION UNDER THE ACT IS UNNECESSARY IN ORDER FOR SUCH TRANSFER TO COMPLY WITH THE ACT AND WITH APPLICABLE STATE SECURITIES LAWS. 

THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE
STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. SUCH TRANSFER RESTRICTIONS ARE BINDING ON TRANSFEREES OF THESE SHARES. 

(b)    Stop Transfer Orders. Participant agrees that, in order to ensure compliance with the restrictions referred
to in the Plan and this Agreement, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same
effect in its own records. 
 (c)    Impermissible Transfers Void. The Company shall not be required (i) to
transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or
other transferee to whom such Shares shall have been so transferred. 

  
 A-3 













 7.    Taxes. Participant understands that Participant may
suffer adverse tax consequences as a result of Participant’s purchase or disposition of the Shares. Participant represents that Participant has consulted with any tax consultants Participant deems advisable in connection with the purchase or
disposition of the Shares and that Participant is not relying on the Company for any tax advice. Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. Participant understands
that Participant (and not the Company) shall be responsible for Participant’s tax liability that may arise as a result of the transactions contemplated by this Agreement. 

8.    Miscellaneous. 

(a)    No Right To Employment or Other Status. No person shall have any claim or right to be granted an Award, and
the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship with the Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate its
relationship with a Participant free from any liability or claim under the Plan or this Agreement. 

(b)    Notices. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the
Company in care of the Secretary of the Company at the Company’s principal office or to the then-current email address for the Secretary of the Company, and any notice to be given to Participant shall be addressed to Participant at the
most-recent physical or email address for Participant listed in the Company’s personnel records. By a notice given pursuant to this Section 8(b), either party may hereafter designate a different address for notices to be given to that
party. Any notice which is required to be given to Participant shall, if Participant is then deceased, be given to the person entitled to exercise his or her Option by written notice under this Section 8(b). Any notice shall be deemed duly
given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. 

(c)    Successors and Assigns. The Company may assign any of its rights under this Agreement and the Exercise Notice
to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Agreement shall be binding upon Participant and his or her
heirs, executors, administrators, successors and assigns. 
 (d)    Severability. In the event any portion of the
Plan or this Agreement or any action taken pursuant thereto shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan and this Agreement, and the Plan and this Agreement shall be
construed and enforced as if the illegal or invalid provisions had not been included, and the illegal or invalid action shall be null and void. 

(e)    Entire Agreement; Governing Documents. The Plan, the Grant Notice and this Agreement (including all Exhibits
thereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof. In the event of any contradiction between the
Plan and any Award Agreement or any other written agreement between a Participant and the Company that has been approved by the Administrator, the terms of the Plan shall govern, unless it is expressly specified in such Award Agreement or other
written document that a specific provision of the Plan shall not apply. 
 (f)    Governing Law. The
provisions of the Plan and all Awards made thereunder, including the Option, shall be governed by and interpreted in accordance with the laws of the State of Delaware, disregarding
choice-of-law principles of the law of any state that would require the application of the laws of a jurisdiction other than such state. 

  
 A-4 













 (g)    Titles and Headings. The titles and headings of the
Sections in this Agreement are for convenience of reference only and, in the event of any conflict, the text of this Agreement, rather than such titles or headings, shall control. 

  
 A-5 













 EXHIBIT B 

TO STOCK OPTION GRANT NOTICE 

FORM OF EXERCISE NOTICE 

Effective as of today,                 ,
                , the undersigned (“Participant”) hereby elects to exercise Participant’s option to purchase
                 Shares of Oncternal Therapeutics, Inc. (the “Company”) under and pursuant to the
Oncternal Therapeutics, Inc. 2015 Equity Incentive Plan (the “Plan”) and the Stock Option Grant Notice and Stock Option Agreement dated
                ,          (the “Agreement”). Capitalized terms used herein
without definition shall have the meanings given in the Agreement. 
  

			
	Grant Date:	  	                                     
                                         
      
		
	Number of Shares as to which Option is Exercised:	  	  

		
	Exercise Price per Share:	  	$                        
		
	Total Exercise Price:	  	$                        
		
	Certificate to be issued in name of:	  	  

		
	Cash Payment delivered herewith:	  	$                             (Representing the full Exercise Price for the
Shares, as well as any applicable withholding tax)

 Type of Option:
            ☐    Incentive Stock
Option                ☐    Non-Qualified Stock Option 

1.    Representations of Participant. Participant acknowledges that Participant has received, read and
understood the Plan and the Agreement. Participant agrees to abide by and be bound by their terms and conditions. Participant further acknowledges that it is a condition to the issuance of the Shares to Participant upon exercise of the Option listed
above that Participant agree to be bound by the terms and conditions of, and become a party to, any stockholders’ agreement of the Company. Participant hereby agrees to be so bound and to execute any additional documents as may be deemed
necessary or advisable by the Company in order to effectuate the foregoing agreement. 
 2.    Tax
Consultation. Participant understands that Participant may suffer adverse tax consequences as a result of Participant’s purchase or disposition of the Shares. Participant represents that Participant has consulted with any tax
consultants Participant deems advisable in connection with the purchase or disposition of the Shares and that Participant is not relying on the Company for any tax advice. Participant is relying solely on such advisors and not on any statements or
representations of the Company or any of its agents. Participant understands that Participant (and not the Company) shall be responsible for Participant’s tax liability that may arise as a result of this investment or the transactions
contemplated by this Agreement. 
 3.    Participant Representations. Participant hereby makes the
following certifications and representations with respect to the Shares listed above: 
 (a)    Participant is aware of
the Company’s business affairs and financial condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Shares. Participant is acquiring these Shares for investment for
Participant’s own account only and not with a view to, or for resale in connection with, any “distribution” thereof within the meaning of the Securities Act. 












 (b)    Participant acknowledges and understands that the Shares
constitute “restricted securities” under the Securities Act and have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of
Participant’s investment intent as expressed herein. Participant understands that the Shares must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available.
Participant further acknowledges and understands that the Company is under no obligation to register the Shares. Participant understands that the certificate evidencing the Shares will be imprinted with a legend which prohibits the transfer of the
Shares unless they are registered or such registration is not required in the opinion of counsel satisfactory to the Company and any other legend required under Applicable Laws. 

(c)    Participant is familiar with the provisions of Rule 701 and Rule 144, each promulgated under the
Securities Act, which, in substance, permit limited public resale of “restricted securities” acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the
satisfaction of certain conditions. Rule 701 provides that if the issuer qualifies under Rule 701 at the time of the grant of the Option to Participant, the exercise will be exempt from registration under the Securities Act. In the event
the Company becomes subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, ninety days thereafter (or such longer period as any market stand-off agreement may require) the
securities exempt under Rule 701 may be resold, subject to the satisfaction of certain of the conditions specified by Rule 144. 

(d)    In the event that the Company does not qualify under Rule 701 at the time of grant of the Option, then the
securities may be resold in certain limited circumstances subject to the provisions of Rule 144. 

(e)    Participant further understands that in the event all of the applicable requirements of Rule 701 or 144 are not
satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption will be required; and that, notwithstanding the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities and
Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules 144 or 701 will have a substantial burden of proof in establishing
that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk. Participant understands that no assurances can be given that
any such other registration exemption will be available in such event. 
 4.    Notices. Any notice
required or permitted hereunder shall be given in accordance with the provisions set forth in Section 8(b) of the Agreement. 

5.    Entire Agreement. The Plan and Agreement are incorporated herein by reference. This Notice, the Plan
and the Agreement constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof. 

 

									
	ACCEPTED BY: 
ONCTERNAL THERAPEUTICS, INC.	 	        	 	SUBMITTED BY 
PARTICIPANT:
	By:	 	  
	 		 	By:	 	  

	Print Name:	 	  
	 		 	Print Name:	 	  

	Title:	 	  
	 		 		 	


  
 B-2